C

Concord Biotech Ltd
NSE:CONCORDBIO

Watchlist Manager
Concord Biotech Ltd
NSE:CONCORDBIO
Watchlist
Price: 2 151.05 INR 0.71%
Market Cap: 225B INR
Have any thoughts about
Concord Biotech Ltd?
Write Note

Balance Sheet

Balance Sheet Decomposition
Concord Biotech Ltd

Current Assets 9.3B
Cash & Short-Term Investments 3.2B
Receivables 3.4B
Other Current Assets 2.7B
Non-Current Assets 8.3B
Long-Term Investments 95.5m
PP&E 8.1B
Intangibles 7.8m
Other Non-Current Assets 133.3m
Current Liabilities 1.4B
Accounts Payable 821.7m
Other Current Liabilities 595.4m
Non-Current Liabilities 322.5m
Long-Term Debt 16.1m
Other Non-Current Liabilities 306.5m

Balance Sheet
Concord Biotech Ltd

Rotate your device to view
Balance Sheet
Currency: INR
Mar-2020 Mar-2021 Mar-2022 Mar-2023 Mar-2024
Assets
Cash & Cash Equivalents
26
608
889
434
470
Cash Equivalents
26
608
889
434
470
Short-Term Investments
1 982
1 411
739
1 663
2 665
Total Receivables
2 113
2 153
2 420
2 933
3 789
Accounts Receivables
1 836
1 790
2 343
2 745
3 508
Other Receivables
277
363
77
188
280
Inventory
1 127
1 550
1 976
2 136
2 156
Other Current Assets
139
350
302
111
201
Total Current Assets
5 386
6 071
6 327
7 277
8 962
PP&E Net
3 809
5 577
6 436
7 655
7 865
PP&E Gross
3 809
5 577
6 436
7 655
7 865
Accumulated Depreciation
692
924
1 378
1 873
2 401
Intangible Assets
1
64
36
2
3
Note Receivable
0
17
36
27
125
Long-Term Investments
62
31
28
103
31
Other Long-Term Assets
147
64
266
76
22
Total Assets
9 405
N/A
11 825
+26%
13 128
+11%
15 140
+15%
17 007
+12%
Liabilities
Accounts Payable
712
464
831
938
944
Accrued Liabilities
0
5
4
3
1
Short-Term Debt
0
51
43
0
0
Current Portion of Long-Term Debt
136
263
266
251
79
Other Current Liabilities
303
274
408
726
398
Total Current Liabilities
1 151
1 057
1 552
1 918
1 422
Long-Term Debt
385
579
316
64
19
Deferred Income Tax
151
175
210
234
281
Other Liabilities
16
21
19
23
20
Total Liabilities
1 703
N/A
1 832
+8%
2 096
+14%
2 240
+7%
1 741
-22%
Equity
Common Stock
95
95
95
105
105
Retained Earnings
6 778
9 069
10 108
11 976
14 342
Additional Paid In Capital
829
829
829
820
820
Other Equity
0
0
0
0
15 162
Total Equity
7 702
N/A
9 994
+30%
11 032
+10%
12 900
+17%
15 266
+18%
Total Liabilities & Equity
9 405
N/A
11 825
+26%
13 128
+11%
15 140
+15%
17 007
+12%
Shares Outstanding
Common Shares Outstanding
105
105
105
105
105

See Also

Discover More